| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |